These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7983189)

  • 1. SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.
    Alkemade JA; Molhuizen HO; Ponec M; Kempenaar JA; Zeeuwen PL; de Jongh GJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC; Schalkwijk J
    J Cell Sci; 1994 Aug; 107 ( Pt 8)():2335-42. PubMed ID: 7983189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.
    Molhuizen HO; Alkemade HA; Zeeuwen PL; de Jongh GJ; Wieringa B; Schalkwijk J
    J Biol Chem; 1993 Jun; 268(16):12028-32. PubMed ID: 7685029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.
    Schalkwijk J; van Vlijmen IM; Alkemade JA; de Jongh GJ
    J Invest Dermatol; 1993 Apr; 100(4):390-3. PubMed ID: 8454901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.
    Van Ruissen F; de Jongh GJ; Zeeuwen PL; Van Erp PE; Madsen P; Schalkwijk J
    J Cell Physiol; 1996 Aug; 168(2):442-52. PubMed ID: 8707880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?
    Kuijpers AL; Zeeuwen PL; de Jongh GJ; van de Kerkhof PC; Alkemade HA; Schalkwijk J
    Arch Dermatol Res; 1996 Oct; 288(11):641-7. PubMed ID: 8931865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.
    Pfundt R; van Ruissen F; van Vlijmen-Willems IM; Alkemade HA; Zeeuwen PL; Jap PH; Dijkman H; Fransen J; Croes H; van Erp PE; Schalkwijk J
    J Clin Invest; 1996 Sep; 98(6):1389-99. PubMed ID: 8823304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of SKALP/elafin during wound healing in human skin.
    van Bergen BH; Andriessen MP; Spruijt KI; van de Kerkhof PC; Schalkwijk J
    Arch Dermatol Res; 1996 Jul; 288(8):458-62. PubMed ID: 8844125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis.
    Nonomura K; Yamanishi K; Yasuno H; Nara K; Hirose S
    J Invest Dermatol; 1994 Jul; 103(1):88-91. PubMed ID: 8027586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographic relation between skin-derived antileukoproteinase (SKALP) and leukocyte elastase in a case of annular pustular psoriasis.
    Kuijpers AL; Alkemade HA; Schalkwijk J; van de Kerkhof PC
    Acta Derm Venereol; 1995 Mar; 75(2):110-3. PubMed ID: 7604637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
    Alkemade H; van de Kerkhof P; Schalkwijk J
    J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.
    Schalkwijk J; de Roo C; de Jongh GJ
    Biochim Biophys Acta; 1991 Feb; 1096(2):148-54. PubMed ID: 2001428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.
    Alkemade HA; de Jongh GJ; Arnold WP; van de Kerkhof PC; Schalkwijk J
    J Invest Dermatol; 1995 Feb; 104(2):189-93. PubMed ID: 7829874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway.
    Pfundt R; Wingens M; Bergers M; Zweers M; Frenken M; Schalkwijk J
    Arch Dermatol Res; 2000 Apr; 292(4):180-7. PubMed ID: 10836611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of SKALP/Elafin in human epidermal tumors.
    Alkemade HA; Molhuizen HO; van Vlijmen-Willems IM; van Haelst UJ; Schalkwijk J
    Am J Pathol; 1993 Dec; 143(6):1679-87. PubMed ID: 8256855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma.
    Alkemade HA; van Vlijmen-Willems IM; van Haelst UJ; van de Kerkhof PC; Schalkwijk J
    J Pathol; 1994 Oct; 174(2):121-9. PubMed ID: 7965407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a keratinocyte-based screening model for antipsoriatic drugs using green fluorescent protein under the control of an endogenous promoter.
    Pol A; van Ruissen F; Schalkwijk J
    J Biomol Screen; 2002 Aug; 7(4):325-32. PubMed ID: 12230886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid.
    Kuijpers AL; Bergers M; Siegenthaler G; Zeeuwen PL; van de Kerkhof PC; Schalkwijk J
    Acta Derm Venereol; 1997 Jan; 77(1):14-9. PubMed ID: 9059669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13.
    Molhuizen HO; Zeeuwen PL; Olde Weghuis D; Geurts van Kessel A; Schalkwijk J
    Cytogenet Cell Genet; 1994; 66(2):129-31. PubMed ID: 8287685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis.
    Kuijpers AL; Schalkwijk J; Rulo HF; Peperkamp JJ; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 1997 Jul; 137(1):123-9. PubMed ID: 9274639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis.
    Nagpal S; Thacher SM; Patel S; Friant S; Malhotra M; Shafer J; Krasinski G; Asano AT; Teng M; Duvic M; Chandraratna RA
    Cell Growth Differ; 1996 Dec; 7(12):1783-91. PubMed ID: 8959347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.